SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.

SeaStar Medical Holding Corporation

SeaStar Medical is a medical device company developing novel cell-directed extracorporeal therapies to fight the life-threatening consequences of hyperinflammation.

SeaStar Medical

PRESS RELEASE: First Patient Enrolled in SeaStar Medical’s Pivotal Clinical Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury

Read the full release here: https://lnkd.in/ene8c5HJ

#pressrelease #medical #medicaldevices #clinicaltrials #medtech #ICU

SeaStar Medical is proud to announce our sponsorship of the inaugural season of the Critical Care Time (www.criticalcaretime.com) podcast by co-creators Nick Mark, MD (of ICU Onepager fame!) & Cyrus Askin, MD.

See the press release HERE: https://lnkd.in/enbP3puq

 #CritCareTime #ICU #OnePagerICU

At SeaStar Medical, we are fighting the effects of a dysregulated immune response. Here’s a closer look at how our novel Selective Cytopheretic Device (SCD) deactivates inflammatory neutrophils & monocytes to restore immune balance.

#MedDevice #ICU #immunesystem #medical

Learn how our Selective Cytopheretic Device (SCD) modulates immune effector cells responsible for a dysregulated immune response.

#MedTech #MedDevice #SCD #AKI #ICU

At SeaStar Medical, we are fighting the effects of a dysregulated immune response. Learn how this imbalance drives hyperinflammation and damage in acute kidney injury. More info at https://bit.ly/3PixGJE

#Hyperinflammation #AKI #ICU $ICU

SeaStar Medical to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 21, 2023. Sign up now: https://lnkd.in/eTbbvsa3

Full Press Release: https://lnkd.in/eW5Da9e2
 
 #ICU #SeaStar #Hyperinflammation #CellDirectedTherapy #Kidney $ICU

SeaStar Medical is proud to support the ADQI Conference on Extracorporeal Therapies, June 9-12 in Vicenza, Italy

Learn more about ADQI's important initiatives at https://bit.ly/3Cpkrz6

#AKI #CriticalCare #ICU

Today our CMO, Dr. Kevin Chung, will be delivering "Novel Targets for Blood Purification - Pathogens, Endotoxins, Neutrophils, Oh My!" for the 7th Annual Southern California Kidney Symposium at 2PM PST - tune in to hear this exciting talk! https://lnkd.in/eRBGcSrK

#AKI #ICU $ICU

Hear from our very own Chief Medical Officer, Dr. Kevin Chung, on Novel Targets for Blood Purification this Friday June 9th at 2pm PST at the 7th Annual Southern California Kidney Symposium

Register now for this hybrid event: https://lnkd.in/eRBGcSrK

#AKI #ICU $ICU

	Dec '20	Dec '21	Dec '22	Dec '23
account payables	382K -	85K 77.75%	1.93M 2,167.06%	5.04M 161.65%
accumulated other comprehensive income loss
cash and cash equivalents	2.81M -	510K 81.83%	47K 90.78%	73K 55.32%
cash and short term investments	2.81M -	510K 81.83%	47K 90.78%	73K 55.32%
common stock			1K -	3K 200%
deferred revenue		186K -
deferred revenue non current
deferrred tax liabilities non current
goodwill
goodwill and intangible assets
intangible assets
inventory	55K -
long term debt	63K -	244K 287.30%	7.65M 3,036.07%	5.72M 25.22%
long term investments
net debt	-2.72M -	2.11M 177.53%	8.78M 315.86%	10.05M 14.47%
net receivables		58K -	12K 79.31%
other assets
other current assets				2.17M -
other current liabilities	678K -	657K 3.10%	2.25M 241.70%	2.98M 32.78%
other liabilities
other non current assets	2K -	2K 0%	1.73M 86,450%	2K 99.88%
other non current liabilities	73.35M -	73.40M 0.07%
othertotal stockholders equity	133K -	147K 10.53%	91.09M 61,865.31%	99.78M 9.54%
preferred stock
property plant equipment net
retained earnings	-71.72M -	-76.31M 6.41%	-99.33M 30.16%	-115.68M 16.47%
short term debt	20K -	2.38M 11,790%	1.18M 50.46%	4.41M 273.94%
short term investments
tax assets
tax payables
total assets	2.91M -	603K 79.27%	4.77M 690.55%	2.25M 52.86%
total current assets	2.91M -	601K 79.33%	3.04M 405.16%	2.25M 26.05%
total current liabilities	1.08M -	3.12M 188.89%	5.35M 71.47%	12.43M 132.30%
total debt	83K -	2.62M 3,059.04%	8.83M 236.77%	10.13M 14.69%
total investments
total liabilities	74.49M -	76.77M 3.06%	13.00M 83.06%	18.15M 39.59%
total liabilities and stockholders equity	2.91M -	603K 79.27%	4.77M 690.55%	2.25M 52.86%
total non current assets	2K -	2K 0%	1.73M 86,450%	2K 99.88%
total non current liabilities	73.41M -	73.65M 0.32%	7.65M 89.61%	5.72M 25.22%
total stockholders equity	-71.58M -	-76.17M 6.40%	-8.23M 89.19%	-15.90M 93.11%

COM:SEASTARMEDICAL

SeaStar Medical

Last Close

2.20

22/11 21:00

Market Cap

25.99M

Beta: -

Volume Today

141.03K

Avg: -

Preview